Cláudia Marchetti

Agostino Gemelli University Polyclinic — Italy

Medicine · Health Sciences

39h-index5.4kcitations335works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Ovarian cancer diagnosis and treatment(196), PARP inhibition in cancer therapy(81), Endometrial and Cervical Cancer Treatments(58), BRCA gene mutations in cancer(58), Intraperitoneal and Appendiceal Malignancies(39)

Publications333 total

Prognostic value of Systemic Inflammation Index (SII) in advanced or recurrent endometrial cancer (EC) patients treated with pembrolizumab and lenvatinib: retrospective observational study experience
2026Open Access
Predictors of Successful Neoadjuvant Chemotherapy and Interval Cytoreductive Surgery in Management of Ovarian Cancer
JCO Oncology Practice·2025Open Access
PARPi and myeloid neoplasms; the Italian MITO-MaNGO experience based on a multicentric survey
ESMO Open·2025Open Access
Engineering ovarian tissue via biofabrication and <scp>3D</scp> bioprinting: Challenges and emerging perspectives
Bioengineering & Translational Medicine·2025Open Access
Real-life observational study on niraparib in older patients with primary tubo-ovarian cancer: a focus on safety and efficacy
International Journal of Clinical Oncology·2025Open Access
Olaparib dose reduction in BRCA-mutated platinum-sensitive ovarian cancer recurrence: real-world data
International Journal of Gynecological Cancer·2025
Breakthrough Invasive Mould Infections Under Posaconazole Prophylaxis in Patients With Haematologic Malignancies: A Case–Control Study
Mycoses·2025Open Access
1109P Upfront treatment strategies for high-grade serous ovarian cancer: Prognostic impact across molecular subtypes in a retrospective cohort
Annals of Oncology·2025
Brain metastases from ovarian cancer: neuroradiological profile and survival overview of neurosurgical cases
Journal of Neuro-Oncology·2025
Response to letter re: Benefit from maintenance with PARP inhibitor in newly diagnosed ovarian cancer according to BRCA1/2 mutation type and site: a multicenter real-world study
ESMO Open·2025Open Access
Response to letter re: Benefit from maintenance with PARP inhibitor in newly diagnosed ovarian cancer according to BRCA1/2 mutation type and site: a multicenter real-world study
ESMO Open·2025· 1 citedOpen Access
Outcome Predictors of <i>Candida</i> Prosthetic Joint Infections: A Systematic Review and Meta-analysis
Open Forum Infectious Diseases·2025Open Access
Extending the timing for secondary cytoreductive surgery after second-line chemotherapy in relapsed ovarian cancer: the EXTENSION study
International Journal of Gynecological Cancer·2025
Failure of early interval debulking surgery after standard neoadjuvant chemotherapy: May bevacizumab add something? A large retrospective study
European Journal of Surgical Oncology·2025
Treatment of Oligometastatic Parenchymal Lesions in Ovarian Cancer With Stereotactic Ablative Radiation Therapy: A Multicenter Prospective Phase 2 Trial (MITO RT3/RAD)
International Journal of Radiation Oncology*Biology*Physics·2025· 2 cited
Integrating clinical-molecular data to predict PARP inhibitors efficacy in advanced ovarian cancer patients after interval cytoreductive surgery
Gynecologic Oncology·2025· 1 citedOpen Access
Assessment Of The Predictive Role Of Khorana Score And Genomic Profiling In Ovarian Cancer-Related Venous Thromboembolism
International Journal of Gynecological Cancer·2025
Adjuvant Chemotherapy In “intermediate-Risk” Early-Stage Ovarian Cancer.
International Journal of Gynecological Cancer·2025
Comprehensive Genomic Characterization Of Primary Ovarian Leiomyosarcoma: Analysis Of Seven Cases
International Journal of Gynecological Cancer·2025Open Access
Outcomes Of Secondary Cytoreductive Surgery In Patients With Platinum-Sensitive Recurrent Ovarian Cancer Progressed After Prior Poly Adenosine Diphosphate-Ribose Polymerase Inhibitors (PARP-I) Maintenance: A Case-Control Study
International Journal of Gynecological Cancer·2025
page 1 of 17Next →

Frequent Co-authors

Pierluigi Benedetti Panici(38), Ludovico Muzii(24), Innocenza Palaia(19), Angela Musella(18), Violante Di Donato(17), Giorgia Perniola(16), Francesca De Felice(14), Giovanni Scambia(12), Vincenzo Tombolini(9), Anna Fagotti(9), Marco Monti(8), Gennaro Cormio(6), Federica Tomao(6), Alessia Romito(5), Margherita Giorgini(5), Laura Vertechy(5), Sandro Pignata(4), Francesco Raspagliesi(4), Gabriella Ferrandina(4), Domenica Lorusso(4)